JAMA Network · Oncology

JAMA Oncology: acceptance rate, review time, and how to prepare

In 2025, JAMA Oncology received 3,738 manuscripts and accepted 8% overall and 4% of research manuscripts. The median first decision took 3 d without peer review and 33 d with it. Every figure below is quoted from the journal's own Year in Review editorials (2023–2025) and instructions for authors, captured 2026-11-10.

Submission requirementsPreview your manuscript free
Sources: 3 annual editorials · instructions for authors · Scimago 2024
3,738
Manuscripts received, 2025
2,592 research
8%
Acceptance rate, 2025
4% research
3 d
First decision without review, median
2025
33 d
First decision with review, median
2025
Acceptance rate

What is JAMA Oncology’s acceptance rate?

The journal publishes the answer itself. Its 2025 Year in Review editorial reports 3,738 manuscripts received, 2,592 of them research manuscripts, with an overall acceptance rate of 8% and a research acceptance rate of 4%. Across 2023–2025 the research acceptance rate moved from 7% to 4% while submissions rose 33%.

YearAll manuscripts receivedResearch manuscripts receivedAcceptance, overallAcceptance, researchSource
20253,7382,5928%4%JAMA Oncology—The Year in Review, 2025
20243,2642,3608%3%JAMA Oncology—The Year in Review, 2024
20232,8072,22313%7%JAMA Oncology—The Year in Review, 2023
Timelines

How long does JAMA Oncology take to reach a decision?

Median days, as published by the journal. 'Without peer review' is the editorial-triage decision; 'with peer review' is the decision after external review.
YearFirst decision, no reviewFirst decision, with reviewReviewer turnaroundAcceptance to publicationReceipt to publication
20253 d33 d13 d75 d120 d
20243 d53 d13 d119 d169 d
20232 d50 d13 d90 d155 d
2025 Journal Impact Factor as printed in the editorial's table (row "2025 Journal Impact Factor"): 20.1
2024 Journal Impact Factor as printed in the editorial's table (row "2024 Journal Impact Factor"): 22.3
2023 Journal Impact Factor as printed in the editorial's table (row "2023 Journal Impact Factor"): 28.4
JAMA Network peers, latest published year
JournalYearReceivedAcceptance, overallAcceptance, researchNo reviewWith review
JAMA Oncology20253,7388%4%3 d33 d
JAMA202511,52610.4%3.9%2.1 d25 d
JAMA Internal Medicine20254,17812%4%1 d35 d
JAMA Network Open202520,2339.9%—2 d49 d
JAMA Pediatrics20253,32510%5%3 d44 d
JAMA Surgery20253,3219%5%10 d40 d
JAMA Dermatology20253,4137%7%3 d36 d
JAMA Cardiology20252,7939%5%8 d51 d
JAMA Neurology20253,2216%5%4 d35 d
JAMA Psychiatry20252,7258%5%2 d31 d
JAMA Otolaryngology–Head & Neck Surgery20251,73014%10%8 d50 d
JAMA Ophthalmology20252,87410%7%2 d38 d
Other top oncology journals in our 49-journal survey
  • Annals of Oncology: acceptance rate not published; 3 d to first decision; 45 d to acceptance
Trend

How has it changed?

+33%
Manuscripts received, 2023 to 2025
2,807 → 3,738
7% → 4%
Research acceptance rate, 2023 to 2025
50 → 33 d
First decision with review, 2023 to 2025
Rejection

What gets papers rejected at JAMA Oncology?

The Year in Review editorials publish volumes, rates and timelines; they do not itemize reasons for rejection. This is the general evidence, cited.
statistics #1

In a content analysis of 151 medical-education manuscripts, the top reasons for rejection were inappropriate or incomplete statistics, overinterpretation of results, and inappropriate or suboptimal instrumentation. [12][14]

44–76%

Lack of new or useful knowledge was the most common reason for rejection at AJR, accounting for 44–76% of rejections in every country. [3]

2.58 of 9

BMJ reviewers found an average of 2.58 of nine major errors deliberately inserted into a test paper; training raised this only to about 3. [18]

Before you submit

What JAMA Oncology requires.

From the journal's instructions for authors, captured 2026-11-10. Instructions change; verify on the journal's page before submitting.
Original Investigation requirements
  • 3000 words of text for an Original Investigation
  • No more than 5 tables and/or figures
  • Structured abstract
  • Key Points
  • Data Sharing Statement
  • Follow EQUATOR Reporting Guidelines
  • Study Type declaration
Reporting guidelines the journal names
  • EQUATOR Reporting Guidelines ("Follow EQUATOR Reporting Guidelines", listed for each research category)
  • CONSORT flow diagram for randomized clinical trials
  • PRISMA-style flow diagram as an online supplement for systematic reviews
  • Named on the page: CONSORT, STROBE, PRISMA, MOOSE, STARD, TRIPOD, CHEERS, SQUIRE, SRQR, COREQ, STREGA, SPIRIT, AAPOR, TREND
Cover letter: Required, with complete contact information for the corresponding author and a statement of whether related papers have been published, posted or submitted.

What are JAMA Oncology’s word limits by article type?

Printed limits from the journal’s instructions for authors, captured 2026-11-10. Only the categories listed there under these names are shown.
Article typeLimits and required elements
Original Investigation3000 words · ≤5 tables and/or figures · Structured abstract · Key Points · Data Sharing Statement · Study Type · Follow EQUATOR Reporting Guidelines
Brief Report1200 words · 15 references · ≤3 tables and/or figures · Structured abstract · Key Points · Study Type · Data Sharing Statement · Follow EQUATOR Reporting Guidelines
Research Letter800 words · ≤10 references · ≤2 small tables and/or figures · Study Type · No Abstract or Key Points · Supplement allowed only for brief additional Methods · Data Sharing Statement · Follow EQUATOR Reporting Guidelines
Systematic Review (without meta-analysis)3000 words · 50-75 references · ≤5 tables and/or figures · Subtitle should be "A Systematic Review" · Structured abstract · Key Points · Follow EQUATOR Reporting Guidelines
Narrative Review2000-3500 words · 50-75 references · ≤5 tables and/or figures · 3-part structured abstract · No Key Points · Subtitle should be "A Review"
Viewpoint1200 words (or 1000 words with 1 small table or figure) · ≤7 references at submission · ≤4 authors, with no more than 2 affiliations per author
Special Communication3000 words · 50 references · ≤4 tables and/or figures · Structured abstract · Requires a presubmission inquiry
Letter to the Editor400 words · ≤5 references (1 of which should be to the recent article) · ≤3 authors
Preparing a manuscript for JAMA Oncology?

The free preview runs on your own manuscript in about two minutes: study design and reporting guideline detected, every reference checked against PubMed and Crossref with a retraction screen, and a reporting-checklist coverage scan. Preview your manuscript free.

Protected by Anthropic’s Zero Data Retention
Your manuscript is never stored, logged, or used for training.
FAQ

Questions, answered.

Don't see yours? Email us — we read every one.

Sources

Where every number on this page comes from.

  1. Disis ML. JAMA Oncology—The Year in Review, 2025. Published online March 19, 2026; JAMA Oncol. 2026;12(5):453–454. JAMA Oncology—The Year in Review, 2025 (captured 2026-11-10).
  2. Disis ML. JAMA Oncology—The Year in Review, 2024. Published online March 20, 2025; JAMA Oncol. 2025;11(5):483–484. JAMA Oncology—The Year in Review, 2024 (captured 2026-11-10).
  3. Disis ML. JAMA Oncology—The Year in Review, 2023. Published online March 21, 2024; JAMA Oncol. 2024;10(5):571–572. JAMA Oncology—The Year in Review, 2023 (captured 2026-11-10).
  4. JAMA Oncology. Instructions for Authors. jamanetwork.com/journals/jamaoncology/pages/instructions-for-authors (captured 2026-11-10).
  5. Scimago Journal Rank, 2024 edition: SJR 8.377, Q1, H-index 193, ISSN 23742445, 23742437.

Submit to JAMA Oncology with the checklist already done.

Start with the free preview of your own manuscript: every reference checked against PubMed and Crossref, with a retraction screen. $49 then unlocks the full review: an item-by-item audit against the reporting guideline for your design and the author instructions you provide for JAMA Oncology, with the journal's formatting applied to your .docx as tracked changes. No subscription, no verdict.

Preview your manuscript freeRead a full sample review
For the manuscript you're submitting